Osborne Clarke advised Grifols on the deal while Greenberg Traurig, LLP represented Tiancheng Investment Management and its portfolio company Bio Products Laboratory. Grifols executed the $370…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
